Leadership

Ramzi Salloum, Ph.D., will be responsible for overseeing the center-wide effort to reduce the burden of cancer.

The committee guides and implements activities to disseminate best practices across AACI cancer center clinical trials offices.

Thomas George, M.D., FACP, becomes deputy director and Paul Crispen, M.D., becomes associate director for clinical research.

John R. Wingard, M.D., retires after 27 years at the University of Florida and made an immeasurable impact on patients, faculty and trainees.

Jonathan D. Licht, M.D., spoke with the Cancer Letter about achieving NCI designation.

Ji-Hyun Lee, DrPH, will serve as ASA president-elect starting Jan. 1, 2024, with her term as president beginning Jan. 1, 2025.

Thomas George, M.D., FACP, and Merry Jennifer Markham, M.D., FACP, FASCO, were honored for exemplifying cancer care advocacy in 2022.

Ji-Hyun Lee, DrPH, director of the division of quantitative sciences at the Cancer Center, is one of two candidates for ASA president.

The University of Florida Health Cancer Center is pleased to announce two leadership changes that will further the center’s goal of advancing innovation and excellence in cancer research, care, deliv-ery and education.

Congratulations to the UF Health Cancer Center Director, Jonathan Licht, M.D., for receiving the 2021 ASH Mentor Award. The ASH Honorific Awards are the Society’s most prestigious awards, recognizing individuals within the global hematology community who have made significant contributions to the field. These…